Meda AB: Acnex Filed in Europe

GÖTEBORG, Sweden--(BUSINESS WIRE)-- The marketing authorization application for Acnex (clindamycin with tretinoin) has been submitted to the European regulatory authorities. Acnex is a new product for treatment of mild to severe acne vulgaris. It’s patented and formulated as a once-daily gel. More than 4,000 patients have been included in clinical studies.